Publications
Publications
Show Results For
- All HBS Web
(25)
- Faculty Publications (5)
Page 1 of 5
Results
- May 2024
- Case
Mission Veterinary Partners
By: Boris Groysberg, Zeeshan Ali and Annelena Lobb
After five successful years, Mission Veterinary Partners (MVP) had to decide on the best way to scale. MVP owned 300 animal hospitals and competed with other consolidators to buy more small veterinary practices. MVP had to distinguish itself as the buyer of choice but... View Details
- September 2020
- Case
Summit Partners: Independent Vetcare
By: Victoria Ivashina and Terrence Shu
This case follows Summit Partners, a leading growth equity firm, as it evaluates an investment opportunity in IVC, a veterinary care group in the U.K. market. The case allows students to articulate and evaluate the investment thesis of this transaction. Additionally,... View Details
- January 2014 (Revised January 2014)
- Case
Henry Schein: Doing Well by Doing Good?
By: Rebecca Henderson, Raffaella Sadun, Aldo Sesia and Russell Eisenstat
Henry Schein Inc., a distributor of supplies to dentist, physician, and veterinary practices, had sales approaching $9 billion and employed nearly 16,000 people. The company had experienced impressive growth under the leadership of Stanley Bergman and his executive... View Details
Keywords: Leadership Development; Strategy Execution; Performance Management; Corporate Culture; Social Responsibility; Mergers ＆ Acquisitions; Joint Ventures; Partnerships; Health Care Industry; Healthcare Logistics Industry; Competitive Advantage; Strategy; Leadership; Global Strategy; Selection and Staffing; Management Style; Organizational Culture; Corporate Social Responsibility and Impact; Health Industry; Medical Devices and Supplies Industry; China; Europe; United States
- February 2000 (Revised March 2000)
- Case
Pet Doctors: 1999
By: Paul A. Gompers and David James Alexander Grant
Describes the decisions confronting David Hodges and Garret Turley about whether to grow their chain of veterinary clinics in the United Kingdom. Turley and Hodges must decide whether to attempt to speed up their acquisition pace and raise venture capital. View Details
- May 1998 (Revised May 1999)
- Case
Biopure Corp.
It is early 1998 and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten-year history, has just received government approval to release Oxyglobin, a revolutionary new "blood substitute" designed to replace the need for donated animal blood... View Details